Sign inJoin waitlistJoin the waitlist

HH

Houston Holmes

Physician · Texas Oncology

Credentials: · · · · ·

History

Texas Oncology
Present

Hematology and Medical Oncology
National Institutes of Health
1993–1996
Internal Medicine
Baylor University Medical Center
1990–1991
Univ of Texas Southwestern Med Sch at Dallas
1986–1990

Research

KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
New England Journal of Medicine · 2020 · 1,512 citations
Three-Year Follow-Up of KTE-X19 in Patients With Relapsed/Refractory Mantle Cell Lymphoma, Including High-Risk Subgroups, in the ZUMA-2 Study
Journal of Clinical Oncology · 2023 · 292 citations
Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation
Journal of Clinical Oncology · 2002 · 231 citations

JP
John Pagel
3 papers
Amer Beitinjaneh
2 papers
Andre Goy
2 papers
Brian Hill
2 papers
Caron Jacobsen
2 papers
David Miklos
2 papers
FL
Frederick Locke
2 papers
Gary Schiller
2 papers
IF
Ian Flinn
2 papers
JM
Javier Munoz
2 papers
John Timmerman
2 papers
LW
Luhua Wang
2 papers

Clinical trials

Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Site PI · Recruiting · Phase 2
Allogene Therapeutics
2024–2032
Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL)
Site PI · Recruiting · Phase 1
Imugene Limited
2019–2027
Expanded Access Program for OOS Obe-cel
Site PI · Available
Autolus Limited